Minimum Investment
₹137,200
Price Range
₹326 to ₹343
Lot Size
400 shares
Issue Size
₹214 Cr
About the Company
Incorporated in 2010, Q-Line Biotech Ltd. is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, and distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
Bookbuilding IPO
IPO Objectives
- To meet working capital requirements
- Repayment of certain borrowing availed by the Company, in part or full
- General Corporate Purposes
Important Dates
| Bid/Offer Opens On | 21-05-2026 |
| Bid/Offer Closes On | 25-05-2026 |
| Finalisation of Basis of Allotment | — |
| Initiation of Refunds | — |
| Credit of Shares to Demat | — |
| IPO Listing Date | — |
Grey Market Premium (GMP)
—
Registrar
Purva Sharegistry (India) Pvt.Ltd.
Lead Managers
- Hem Securities Ltd.
- Share India Capital Services Pvt.Ltd.
Company Promoters
- The promoters of the company are Saurabh Garg
- Amita Garg
- Ayush Garg
- Ajay Kumar Mahanty and Abhay Agrawal.\r\n
